Caution, this is an AI generated summary based on literature. This may have errors, see here for more.
Please share your feedback with us.
hsa-mir-1323: Hsa-mir-1323 is a microRNA that is involved in the development of neuroblastoma [PMC6531850]. Higher circulating levels of serum hsa-mir-1323 have also been associated with gestational diabetes mellitus (GDM) [PMC9313007]. Several other microRNAs have been identified as potential regulators of the expression levels of E-cadherin and clusterin, including hsa-miR-320a-3p, hsa-miR-17-5p, hsa-miR-21-5p, hsa-miR-25-3p, hsa-miR-138-5p, hsa-miR-34a-5p, and hsa-miR92a3p [PMC8064394]. Hsa-mir1323 has also been validated as a target for rs3749585 and shown to regulate the expression of CORIN [PMC8365884]. Additionally, it has been found that HsamiRNA1323 is one of the miRNAs that target CXCL1 and CXCL8 [PMC9391105]. Overall, these findings suggest that HsamiRNA1323 plays a role in various biological processes and may have potential implications in neuroblastoma development and GDM.
mRNA interactions
2 total
Genome locations
Gene Ontology annotations
Ancestor Chart
Loading ontology ancestors...
Failed to load QuickGO Ancestor chart
Sequence
Sequence features are shown above as colored rectangles.
Zoom in and click to view details, or
Reset
